The Natural Path
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Annapolis, MD
Annapolis's IV therapy market is shaped by Maryland's capital city status, the United States Naval Academy, and a strong Chesapeake Bay sailing and boating economy. Clinics cluster near downtown Annapolis, in Eastport, and along West Street, with overflow from Severna Park, Arnold, and Edgewater. Anne Arundel Medical Center (Luminis Health) and the broader Johns Hopkins and MedStar networks anchor the clinical ecosystem supplying many medical directors. Maryland is a full-practice state for nurse practitioners, so NP-led IV clinics are common in Annapolis alongside physician-director models. The Naval Academy and state government workforce drive executive wellness demand, the sailing and boating community around Ego Alley and the Spa Creek and Annapolis Harbor area drives hangover and event recovery volume, and summer boating season sustains steady hydration bookings. Mobile IV services reach Severna Park, Arnold, and Kent Island.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Maryland medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.